What is the recommended treatment for bacterial conjunctivitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Bacterial Conjunctivitis

For mild bacterial conjunctivitis, prescribe a 5-7 day course of broad-spectrum topical antibiotic applied 4 times daily, choosing the most convenient or least expensive option such as polymyxin B/trimethoprim, as no evidence demonstrates superiority of any particular agent in uncomplicated cases. 1, 2

Severity-Based Treatment Algorithm

Mild Bacterial Conjunctivitis

  • Topical antibiotic therapy accelerates clinical and microbiological remission by days 2-5, reduces transmissibility, and allows earlier return to school/work, even though most cases are self-limited. 1, 2, 3
  • Apply any broad-spectrum topical antibiotic 4 times daily for 5-7 days 1, 2
  • Acceptable first-line options include:
    • Polymyxin B/trimethoprim 1
    • Erythromycin 1
    • Tobramycin 1
    • Gentamicin 1
  • Reserve fluoroquinolones (ofloxacin, ciprofloxacin, moxifloxacin) for moderate-to-severe cases or contact lens wearers to preserve effectiveness and minimize resistance. 1, 4

Moderate to Severe Bacterial Conjunctivitis

Characterized by copious purulent discharge, pain, and marked inflammation 4, 2:

  • Obtain conjunctival cultures and Gram staining immediately before initiating treatment, especially if gonococcal infection is suspected. 1, 4
  • Prescribe fluoroquinolones as first-line empiric therapy due to broad-spectrum coverage against common pathogens including Staphylococcus aureus, Streptococcus pneumoniae, Haemophilus influenzae, and Pseudomonas. 4
  • Specific fluoroquinolone options:
    • Ciprofloxacin 0.3%: 1-2 drops every 2 hours while awake for 2 days, then every 4 hours while awake for 5 days 5
    • Moxifloxacin 0.5% or ofloxacin 0.3% 4
  • Alternative: Aminoglycosides (tobramycin or gentamicin) 4

Special Pathogen Considerations

Gonococcal Conjunctivitis

  • Requires systemic antibiotic therapy; topical treatment alone is insufficient. 1, 4
  • Add saline lavage for comfort and faster resolution 1
  • Mandatory daily follow-up until complete resolution 4, 2
  • Hospitalization may be necessary for severe cases and is mandatory for neonatal cases 1

Chlamydial Conjunctivitis

  • Requires systemic antibiotic therapy (oral azithromycin single dose or tetracycline for 7 days in adults); topical therapy alone is inadequate. 1, 4
  • For neonates: erythromycin base or ethylsuccinate 50 mg/kg/day divided into 4 doses for 14 days 1
  • Follow-up evaluation is critical as treatment failure occurs in up to 19% of cases 2

MRSA Conjunctivitis

  • MRSA has been isolated with increasing frequency and may require compounded topical vancomycin, as MRSA is resistant to many commercially available topical antibiotics including aminoglycosides. 1, 4
  • Microbiology laboratory testing should guide therapy 4

Contact Lens Wearers

  • Higher risk for Pseudomonas infection; prescribe fluoroquinolones regardless of severity. 1, 4

Alternative Treatment Option

  • Povidone-iodine 1.25% ophthalmic solution may be as effective as topical antibiotics and can be considered when access to antibiotics is limited. 1, 2

Follow-Up Protocol

  • Advise patients to return in 3-4 days if no improvement is noted. 1, 4
  • At follow-up, perform interval history, visual acuity measurement, and slit-lamp biomicroscopy 1, 4
  • For gonococcal conjunctivitis, daily follow-up is mandatory until resolution 4, 2

Immediate Ophthalmology Referral Indications

Refer immediately for: 1, 4

  • Visual loss or decreased visual acuity
  • Moderate or severe pain
  • Severe purulent discharge
  • Corneal involvement (infiltrate, ulceration, opacity)
  • Conjunctival scarring
  • Lack of response to therapy after 3-4 days
  • Recurrent episodes

Critical Pitfalls to Avoid

Antibiotic Resistance

  • Bacterial resistance is a growing concern, particularly with MRSA infections and fluoroquinolone-resistant organisms. 1, 4
  • Individual risk factors for fluoroquinolone resistance include recent fluoroquinolone use, hospitalization, advanced age, and recent ocular surgery 4
  • Approximately 42% of staphylococcal isolates show methicillin resistance with high concurrent fluoroquinolone resistance 4

Inappropriate Corticosteroid Use

  • Avoid topical corticosteroids unless under close ophthalmologic supervision, as they may prolong bacterial shedding and worsen infection. 4
  • If severe inflammation requires corticosteroids, perform baseline and periodic intraocular pressure measurements 1

Misdiagnosis of Viral Conjunctivitis

  • Avoid prescribing antibiotics for viral conjunctivitis, which accounts for unnecessary costs and promotes resistance. 1
  • Viral conjunctivitis is the most common overall cause of infectious conjunctivitis and usually does not require treatment 6

Special Populations

  • In children with gonococcal or chlamydial conjunctivitis, consider the possibility of sexual abuse. 1, 2
  • For children with blepharitis where tetracyclines are contraindicated, use topical antibiotics like tobramycin 1

References

Guideline

Treatment of Bacterial Conjunctivitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Bacterial Conjunctivitis: Frequency and Duration

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Severe Bacterial Conjunctivitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.